Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT06303388

Effects of Bruegger's Exercises Versus Egoscue Exercise on Lower Cross Syndrome

Conditions: Lower Cross Syndrome

Sex: All
Ages: 16 Years – 65 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 34
Sponsor: Riphah International University

Location: Pakistan Railway General Hospital Rawalpindi Federal

Summary

This study aims to find effects of Bruegger's Exercise versus Egoscue exercise on pain and hyperlordosis on patient with lower cross syndrome. This is interventional study which recruits 34 participants ,14 in each group.

Eligibility Criteria

Inclusion Criteria: • Females and males aged between 16 to 65 years * Participants had to present with low back pain * Participants had to meet the criteria for lower crossed syndrome indicating tight hip flexors (Modified Thomas test) and erector spinae (visual assessment through toe touching) together with weak glutei (Prone Hip Extension Co-ordination/Strength Test) and abdominals (Trunk Flexion Co-ordination and Strength Test)and thoracic kyphosis. * Angle of anterior pelvic tilt \> 10 degrees Exclusion Criteria: • Participants who would be undergoing other forms of treatment that may interfere with the study, for the duration of the study, including other manipulative and physical therapies specific to back pain. * Presence of other conditions that may mimic low back pain, e.g. nerve entrapment. * Participants taking any medication that may interfere with the results of this study including, pain medication, anti-inflammatory medication, and muscle relaxants. * Surgery on the back, pelvis, or sacrum is indicated or has previously occurred * LBP having localised or radiating pain. * Practiced any kind of exercise or sports activity during the last 6 months.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06303388). StuddyBuddy aggregates publicly available trial information.